Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Perphenazine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Perphenazine 2mg tablets
0402010Q0AAACAC
|
Perphenazine | Perphenazine | Central Nervous System | 49 |
|
Perphenazine 4mg tablets
0402010Q0AAADAD
|
Perphenazine | Perphenazine | Central Nervous System | 11 |
|
Fentazin 2mg tablets
0402010Q0BBAAAC
|
Fentazin | Perphenazine | Central Nervous System | No data available |
|
Fentazin 4mg tablets
0402010Q0BBABAD
|
Fentazin | Perphenazine | Central Nervous System | No data available |
|
Perphenazine 2mg/5ml oral suspension
0402010Q0AAAKAK
|
Perphenazine | Perphenazine | Central Nervous System | No data available |
|
Perphenazine 4mg/5ml oral suspension
0402010Q0AAALAL
|
Perphenazine | Perphenazine | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.